These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31129936)

  • 21. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).
    Perry RC; Shankar RR; Fineberg N; McGill J; Baron AD;
    Diabetes Care; 2001 Mar; 24(3):465-71. PubMed ID: 11289469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concordance of two diabetes diagnostic criteria using fasting plasma glucose and hemoglobin A1c: the Yuport Medical Checkup Centre study.
    Inoue K; Kashima S; Ohara C; Matsumoto M; Akimoto K
    PLoS One; 2012; 7(10):e47747. PubMed ID: 23082207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.
    Norberg M; Eriksson JW; Lindahl B; Andersson C; Rolandsson O; Stenlund H; Weinehall L
    J Intern Med; 2006 Sep; 260(3):263-71. PubMed ID: 16918824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.
    Hsia DS; Rasouli N; Pittas AG; Lary CW; Peters A; Lewis MR; Kashyap SR; Johnson KC; LeBlanc ES; Phillips LS; Hempe JM; Desouza CV;
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e130-8. PubMed ID: 31965161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative performance of HbA1c 6.5% for FPG ≥7.0 vs 2hr PG≥11.1 criteria for diagnosis of type 2 diabetes.
    Adamu AN
    Afr Health Sci; 2011 Sep; 11(3):421-6. PubMed ID: 22275933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
    Christophi CA; Resnick HE; Ratner RE; Temprosa M; Fowler S; Knowler WC; Shamoon H; Barrett-Connor E; Kahn SE;
    J Diabetes Complications; 2013; 27(2):150-7. PubMed ID: 23140912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of fasting plasma glucose and glycated hemoglobin for diagnosing diabetes in a Taiwanese population.
    Lai YJ; Lee ST; Kuo SC; Chou P
    Metab Syndr Relat Disord; 2015 Jun; 13(5):203-7. PubMed ID: 25734884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose.
    Ho-Pham LT; Nguyen UDT; Tran TX; Nguyen TV
    PLoS One; 2017; 12(8):e0182192. PubMed ID: 28817663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycated haemoglobin and fasting plasma glucose tests in the screening of outpatients for diabetes and abnormal glucose regulation in Uganda: A diagnostic accuracy study.
    Kasujja FX; Mayega RW; Daivadanam M; Kiracho EE; Kusolo R; Nuwaha F
    PLoS One; 2022; 17(8):e0272515. PubMed ID: 35925994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
    Soulimane S; Simon D; Shaw J; Witte D; Zimmet P; Vol S; Borch-Johnsen K; Magliano D; Vistisen D; Balkau B
    Diabetes Res Clin Pract; 2012 Jun; 96(3):392-9. PubMed ID: 21741107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes.
    Monami M; Lamanna C; Lambertucci L; Longo R; Cocca C; Addante F; Lotti E; Masotti G; Marchionni N; Mannucci E
    J Endocrinol Invest; 2006; 29(7):619-24. PubMed ID: 16957410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.
    Chiu HT; Li TC; Li CI; Liu CS; Lin WY; Lin CC
    PLoS One; 2017; 12(5):e0177184. PubMed ID: 28489885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
    Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
    Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine.
    Rosediani M; Azidah AK; Mafauzy M
    Med J Malaysia; 2006 Mar; 61(1):67-71. PubMed ID: 16708736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fasting glucose, HbA1c, or oral glucose tolerance testing for the detection of glucose abnormalities in patients with acute coronary syndromes.
    Hage C; Lundman P; Rydén L; Mellbin L
    Eur J Prev Cardiol; 2013 Aug; 20(4):549-54. PubMed ID: 22456695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.
    Woerle HJ; Pimenta WP; Meyer C; Gosmanov NR; Szoke E; Szombathy T; Mitrakou A; Gerich JE
    Arch Intern Med; 2004 Aug 9-23; 164(15):1627-32. PubMed ID: 15302632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of HbA1c to diagnose type 2 diabetes mellitus among high risk Sri Lankan adults.
    Herath HMM; Weerarathna TP; Dahanayake MU; Weerasinghe NP
    Diabetes Metab Syndr; 2017; 11(4):251-255. PubMed ID: 27623517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.